BRISTOL-MYERS SQUIBB

Lobbying client · District of Columbia · filed 2025 to 2026

biopharmaceutical company

$160,000 Reported spend

5 Filings counted

1 Firms hired

4 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (192152), not by name.

Firms hired 1

CROSSROADS STRATEGIES, LLC $160,000 5 filings

Bills named in these filings 4

S 891
Bipartisan Health Care Act

4 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

3 filings
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…

1 filing
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

1 filing

Reported by year 2 years

2026 $0 1 filing
2025 $160,000 4 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 5 total

1TY

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 19, 2026

View → Q4

CROSSROADS STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $40,000 income · posted Jan 20, 2026

View → Q3

CROSSROADS STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2

CROSSROADS STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $40,000 income · posted Jul 21, 2025

View → Q1

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.